XRF Scientific Limited
ASX:XRF.AX
1.74 (AUD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 59.836 | 55.175 | 40.007 | 31.293 | 29.081 | 29.029 | 24.25 | 21.54 | 21.133 | 20.671 | 21.85 | 23.201 | 25.886 | 20.489 | 12.675 | 16.906 | 14.706 | 12.588 |
Cost of Revenue
| 34.819 | 33.172 | 23.544 | 18.402 | 17.738 | 17.673 | 14.595 | 12.66 | 12.552 | 11.973 | 13.243 | 13.381 | 15.895 | 11.977 | 7.867 | 10.229 | 9.16 | 7.515 |
Gross Profit
| 25.017 | 22.002 | 16.463 | 12.891 | 11.344 | 11.356 | 9.655 | 8.88 | 8.581 | 8.698 | 8.607 | 9.82 | 9.992 | 8.513 | 4.809 | 6.677 | 5.547 | 5.073 |
Gross Profit Ratio
| 0.418 | 0.399 | 0.411 | 0.412 | 0.39 | 0.391 | 0.398 | 0.412 | 0.406 | 0.421 | 0.394 | 0.423 | 0.386 | 0.415 | 0.379 | 0.395 | 0.377 | 0.403 |
Reseach & Development Expenses
| 0 | 0.094 | 0.112 | 0.151 | 0.179 | 0.18 | 0.189 | 0.18 | 0.15 | 0.074 | 0.078 | 0.169 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 11.812 | 9.169 | 7.763 | 6.749 | 6.727 | 6.573 | 6.424 | 5.984 | 4.895 | 4.004 | 3.76 | 3.59 | 3.472 | 2.302 | 2.321 | 4.134 | 3.804 | 3.906 |
Selling & Marketing Expenses
| -1.25 | 0.074 | -0.087 | -0.235 | -0.221 | 0.674 | 0.723 | 0.844 | 0.706 | 0.612 | 0.616 | 0 | 0 | 0 | 0 | 0.112 | 0.106 | 0.372 |
SG&A
| 10.562 | 9.242 | 7.676 | 6.514 | 6.506 | 7.247 | 7.147 | 6.828 | 5.602 | 4.615 | 4.377 | 3.59 | 3.472 | 2.302 | 2.321 | 4.246 | 3.911 | 4.278 |
Other Expenses
| 0.011 | 0.04 | 0.029 | 0.86 | 0.291 | 0.025 | -0.164 | 0.037 | 0.151 | 0.258 | 0.193 | -0.065 | -0.05 | -0.057 | -0.041 | 0.002 | 0.057 | 0.018 |
Operating Expenses
| 10.562 | 9.242 | 7.676 | 6.514 | 6.506 | 8.099 | 8.054 | 7.865 | 6.18 | 5.054 | 5.066 | 4.348 | 4.821 | 4.258 | 3.944 | 4.559 | 4.201 | 4.511 |
Operating Income
| 14.455 | 12.76 | 8.787 | 6.377 | 4.838 | 3.335 | 1.764 | 1.271 | 2.371 | 3.63 | 3.781 | 4.725 | 4.776 | 4.229 | 0.719 | 2.118 | 1.322 | 0.64 |
Operating Income Ratio
| 0.242 | 0.231 | 0.22 | 0.204 | 0.166 | 0.115 | 0.073 | 0.059 | 0.112 | 0.176 | 0.173 | 0.204 | 0.184 | 0.206 | 0.057 | 0.125 | 0.09 | 0.051 |
Total Other Income Expenses Net
| -0.991 | -0.971 | -0.594 | 0.411 | -0.384 | -0.183 | -0.262 | -0.302 | 0.003 | 0.013 | -0.239 | -0.019 | -0.05 | -0.387 | -0.34 | 0.002 | 0.057 | -0.109 |
Income Before Tax
| 13.464 | 11.789 | 8.193 | 6.788 | 4.454 | 3.151 | 1.502 | 0.968 | 2.373 | 3.643 | 3.541 | 5.442 | 5.089 | 3.732 | 0.522 | 2.308 | 1.552 | 0.642 |
Income Before Tax Ratio
| 0.225 | 0.214 | 0.205 | 0.217 | 0.153 | 0.109 | 0.062 | 0.045 | 0.112 | 0.176 | 0.162 | 0.235 | 0.197 | 0.182 | 0.041 | 0.137 | 0.106 | 0.051 |
Income Tax Expense
| 3.967 | 3.608 | 2.099 | 1.657 | 1.333 | 1.014 | 0.478 | 0.175 | 0.836 | 1.004 | 1.1 | 1.63 | 1.484 | 1.097 | 0.219 | 0.358 | 0.515 | 0.253 |
Net Income
| 8.885 | 7.686 | 6.084 | 5.13 | 3.121 | 2.138 | 1.024 | 0.794 | 1.537 | 2.639 | 2.441 | 3.813 | 3.579 | 2.635 | 0.303 | 1.951 | 0.921 | 0.108 |
Net Income Ratio
| 0.148 | 0.139 | 0.152 | 0.164 | 0.107 | 0.074 | 0.042 | 0.037 | 0.073 | 0.128 | 0.112 | 0.164 | 0.138 | 0.129 | 0.024 | 0.115 | 0.063 | 0.009 |
EPS
| 0.065 | 0.056 | 0.045 | 0.038 | 0.023 | 0.016 | 0.008 | 0.006 | 0.012 | 0.02 | 0.019 | 0.029 | 0.028 | 0.025 | 0.003 | 0.021 | 0.012 | 0.001 |
EPS Diluted
| 0.065 | 0.056 | 0.045 | 0.038 | 0.023 | 0.016 | 0.008 | 0.006 | 0.012 | 0.02 | 0.018 | 0.029 | 0.028 | 0.025 | 0.003 | 0.021 | 0.011 | 0.001 |
EBITDA
| 16.027 | 13.965 | 9.965 | 7.611 | 6.083 | 4.009 | 2.43 | 1.858 | 2.942 | 4.151 | 4.257 | 5.754 | 5.84 | 4.746 | 1.15 | 2.591 | 1.86 | 0.926 |
EBITDA Ratio
| 0.268 | 0.253 | 0.249 | 0.243 | 0.209 | 0.138 | 0.1 | 0.086 | 0.139 | 0.201 | 0.195 | 0.248 | 0.226 | 0.232 | 0.091 | 0.153 | 0.126 | 0.074 |